This inventor holds 1 USPTO granted patent. Top assignee: Sapporo Breweries Limited. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Nobuyasu Enoki: Innovator in Antitumor Compounds
Introduction
Nobuyasu Enoki is a notable inventor based in Yaizu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor substances. His innovative work has led to the creation of novel compounds that hold promise for cancer treatment.
Latest Patents
Enoki holds a patent for HP530 compounds and the process for preparing the same. This patent discloses novel HP530 compounds, their derivatives, or their pharmaceutically permissible salts. The process involves cultivating Streptomyces sp. HP530 (FERM BP-2786) or through chemical derivation. The compounds are characterized by a general formula that includes various acyl groups and specific structural components.
Career Highlights
Nobuyasu Enoki is currently associated with Sapporo Breweries Limited, where he applies his expertise in pharmaceutical research. His work has been instrumental in advancing the understanding and development of antitumor agents.
Collaborations
Enoki has collaborated with notable colleagues, including Naoki Abe and Hideaki Uchida. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Nobuyasu Enoki's contributions to the field of pharmaceuticals, particularly through his patent on HP530 compounds, highlight his role as an innovator in antitumor research. His work continues to impact the development of effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile